Navigation Links
LabCentral Adds Eppendorf as a Major Sponsor of the Cambridge Launchpad for Life Science Startups
Date:9/30/2013

CAMBRIDGE, Mass., Sept. 30, 2013 /PRNewswire/ -- LabCentral, an innovative, shared laboratory space designed to be a catalyst for high-potential entrepreneurs and life-sciences startups, reached another milestone last week with the addition of Eppendorf North America as a major sponsor. Eppendorf North America is the U.S. subsidiary of the Hamburg/Germany-based maker of quality laboratory equipment. Slated for opening November 1, 2013, LabCentral will become the first flexible, affordable, fully equipped and resourced lab and office facility in the heart of the Cambridge Biotech Innovation Hub.

"We are excited to become partners of LabCentral and proud to support LabCentral's mission to advance the life sciences in this innovative cluster," said President and CEO of Eppendorf North America, Matin Khajooei. "Eppendorf has a long tradition of supporting scientists in their work with best-in-class products and support. LabCentral's model is unique and will change the way biotechnology companies are built in the future," he added.

LabCentral received a competitive $5 million capital grant from the Massachusetts Life Science Center in February 2013, Triumvirate Environmental and Johnson & Johnson Innovation became founding sponsors shortly thereafter, and Edwards Wildman Palmer, LLP joined in the platinum category. Gold sponsors include Novartis Institutes for Biomedical Research, Cushman & Wakefield, and Cooley, LLP. MIT Investment Management Co. is LabCentral's real estate partner. Additional LabCentral sponsors include Ambit Creative, Kendall Press, Silicon Valley Bank, Steady Vision, and Union Office Interiors.

Commenting on the addition of Eppendorf to its growing list of sponsors, LabCentral President and Executive Director Johannes Fruehauf, said, "It is great to find committed partners like Eppendorf who share our
'/>"/>

SOURCE LabCentral
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Eppendorf Video Features Dr Andrew Holts Work on Bioactive Leachates From Plastic Consumables
2. Major Pipette Distributor Pipette.com Now Stocks Eppendorf Consumables: Eppendorf Microcentrifuge Tubes, CombiTips, Deep Well Plates and EP Pipette Tips
3. Northwest Bio Implements Major Balance Sheet Clean-Up
4. Why Medicare Carrier Proposes Major Changes in the Handling of Code Stacked Molecular Test Claims is Topic of December 20 Audio Conference
5. Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase
6. Nanosurgery and the fight against cancer: Major breakthrough at Polytechnique Montral
7. Research could lead to new drugs for major diseases
8. APCER Pharma Sponsors Major Industry Conference
9. LLSs Lead Therapy Acceleration Program in MDS Gets Boost from Major Industry Licensing Agreement
10. Promotion of Young Researchers Supported by Major Donation
11. Major Diabetes Peer-Review Journal Publishes Postive Results Of Ultradian Diagnostics Human Pilot Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... Columbia and MENLO PARK, ... DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar and ... and commercializing proven cancer therapies in new orphan ... the 106th Annual Meeting of the American ... on the potential for its lead product candidate ...
(Date:4/20/2015)... 2015  Ardelyx, Inc. (NASDAQ: ARDX ), ... and metabolic diseases, today announced that Annalisa ... Board of Directors. Dr. Jenkins brings a wealth ... built and led teams advancing programs from scientific ... healthcare systems globally. "Annalisa brings ...
(Date:4/20/2015)... , April 20, 2015  "Everybody is affected ... do to patients is frankly brutal. We,ve got to ... a cancer ward, or witnessed a loved one or ... witnessed firsthand the devastation chemotherapy and other treatments cause ... people want to give up and succumb to the ...
(Date:4/20/2015)... Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products ... the fourth quarter and full year ended December 31, ... the fourth quarter 2013) , Quarterly sales were ... million in the prior year period. Excluding revenue recognized ... $0.1 million in the fourth quarter of 2014 and ...
Breaking Biology Technology:DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 2DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 4DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 5Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 2Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 3Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 4Is Dr. Craig Dionne the Steve Jobs of Cancer Research? 2Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 2Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 3Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 4Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 5Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 6Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 7Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 8Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 9Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 10Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 11Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 12Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 13Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 14Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 15Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 16Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 17Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 18
... 2011 BioSpecifics Technologies Corp. (NASDAQ: BSTC ... products, today announced that there will be three separate ... for the treatment of patients suffering from Dupuytren,s contracture ... Societies for Surgery of the Hand Meeting to be ...
... Children at Paterson Public School No. 5 received ... more than 200 volunteers from Roche, New Jersey Community ... from non-profit KaBOOM!. The new playground provides the 1,300-plus ... well as children living in the neighborhood with a ...
... JOSE, Calif., May 18, 2011 Oclaro, Inc. (NASDAQ: ... communications and laser solutions, today announced that its 9xx ... Pantec Biosolutions, the leading provider of epidermal medical applications, ... Epidermal System) platform. This cutting-edge new laser platform represents ...
Cached Biology Technology:BioSpecifics Technologies Corp. Announces Data Presentations at Upcoming XVI Annual Federation of the European Societies for Surgery of the Hand Meeting 2BioSpecifics Technologies Corp. Announces Data Presentations at Upcoming XVI Annual Federation of the European Societies for Surgery of the Hand Meeting 3BioSpecifics Technologies Corp. Announces Data Presentations at Upcoming XVI Annual Federation of the European Societies for Surgery of the Hand Meeting 4Designed by Kids, Built by Volunteers: Roche, New Jersey Community Development Corporation, and KaBOOM! Build New Playground in Just One Day for Paterson Public School Children 2Designed by Kids, Built by Volunteers: Roche, New Jersey Community Development Corporation, and KaBOOM! Build New Playground in Just One Day for Paterson Public School Children 3Designed by Kids, Built by Volunteers: Roche, New Jersey Community Development Corporation, and KaBOOM! Build New Playground in Just One Day for Paterson Public School Children 4Pantec Biosolutions Selects Oclaro Laser Diode Bars for Transdermal Drug Delivery and Tissue Ablation Systems 2Pantec Biosolutions Selects Oclaro Laser Diode Bars for Transdermal Drug Delivery and Tissue Ablation Systems 3Pantec Biosolutions Selects Oclaro Laser Diode Bars for Transdermal Drug Delivery and Tissue Ablation Systems 4
(Date:4/2/2015)... 2, 2015 According to preliminary ... to somewhat higher than 125 MSEK. This exceeds the ... 2014 that revenues for Q1 2015 would be in ... for Q4 2014. The operating result for the first ... complete interim report will as previously communicated be published ...
(Date:4/1/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces the second shipment ... underway to early access pre-order customers. ... retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, Stop ... accepted at all outlets and very easy to use. ...
(Date:3/31/2015)... NEW YORK , March 31, 2015  Elephant ... the "Company"), a global provider of Software Defined Network ... solutions, today announced total revenue of approximately $20.4 million ... to a restated $19.5 million for the year ended ... of calendar 2014, the Company had completed its multi-year ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... more corals and fish generate predictably greater levels of ... has important implications for understanding the behaviour of young ... environmental health by listening to reefs. Contrary to ... places, with fish and invertebrates producing clicks and grunts ...
... SALT LAKE CITYResearchers at Huntsman Cancer Institute (HCI) at the ... necessary for the maintenance and repair of the cell,s cytoskeleton, ... of the cell. The research has implications for cancer, as ... often associated with disease. The research was published in the ...
... failure of the Deepwater Horizon oil well last spring, nearly ... of Mexico to contain the spill. While preliminary reports suggest ... effect of such a massive volume of dispersant on ecosystems, ... a University at Buffalo researcher with expertise in how the ...
Cached Biology News:Taking the pulse of coral reefs 2Study offers first explanation of how cells rapidly repair and maintain structure 2A less toxic, more efficient dispersant is scientist's goal 2
... Anti-Lipid Phosphate Phosphatase 2 ... buffered aqueous solution ... saline containing 0.08% sodium ... from the human LPP2 ...
Anti-CaM kinase II recognizes the enzymes a subunit (6) and reacts with tissue from all mammalian species tested, as well as with chicken and frog tissues....
... Anti-MAPKAPK-2, Phospho-Specific(Thr 222 ) ... mM NaCl, 10 mM sodium ... glycerol, pH 7.5. Recognizes the ... kinase 2 (MAPKAPK-2) protein phosphorylated ...
Ca2+ Channel Ca gamma 2 Purified Anti-Mouse, Anti-Rat, Anti-Human clone Polyclonal, Isotype Rabbit Ig, 50 µl Consult technical datasheet for details....
Biology Products: